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Virus releaseCholesterol and sphingolipid enriched lipid raft micro-domains in the plasma membrane play an important
role in the life-cycle of numerous enveloped viruses. Although human respiratory syncytial virus (RSV)
proteins associate with the raft domains of infected cells and rafts are incorporated in RSV virion particles,
the functional role of raft during RSV infection was unknown. In the current study we have identiﬁed
rafts as an essential component of host cell that is required for RSV infection. Treatment of human lung
epithelial cells with raft disrupting agent methyl-beta-cyclodextrin (MBCD) led to drastic loss of RSV in-
fectivity due to diminished release of infectious progeny RSV virion particles from raft disrupted cells.
RSV infection of raft deﬁcient Niemann–Pick syndrome type C human ﬁbroblasts and normal human embryonic
lung ﬁbroblasts revealed that during productive RSV infection, raft is required for release of infectious RSV
particles.
© 2011 Elsevier Inc. All rights reserved.Introduction
Paramyxoviruses are enveloped viruses containing a non-segmented
negative strand single-stranded RNA genome. Paramyxoviruses are
important human pathogens known to cause many diseases. All
paramyxoviruses enter cells via direct fusion of the viral lipid-envelope
with the plasma membrane (non-endocytic pathway) and viral
assembly/budding occurs in the host plasma membrane. Human
respiratory syncytial virus (RSV) is a lung-tropic paramyxovirus that
causes high morbidity and mortality among infants, children, and the
elderly (Collins et al., 2007; Hall, 2001; Hippenstiel et al., 2006).
RSV infects the airway to cause respiratory diseases like pneumonia
and bronchiolitis.
Paramyxoviruses like RSV utilize a wide spectrum of cellular pro-
teins during its life cycle. Plasma membrane assembly and release
(budding) of paramyxoviruses is an essential component of viral
life cycle. Several cellular proteins were shown to assist this stage
of viral replication (Gower et al., 2005; Ravid et al., 2010; Utley
et al., 2008). Lipid raft micro-domains in the plasma membrane are
enriched with cholesterol and sphingolipids (Pike, 2003; Silvius,
2003). Due to the presence of cholesterol, the raft domain membrane
possesses an “ordered” rigid structure with limited “ﬂuidity” compared
to the surrounding plasma membrane. Lipid rafts serve as platformsgy & Immunology, The Univer-
03 Floyd Curl Drive, MC-7758,
rights reserved.for plasma membrane assembly and budding of enveloped viruses
like inﬂuenza A virus (Leser and Lamb, 2005; Scheiffele et al., 1999;
Takeda et al., 2003; Xiangjie and Whittaker, 2003), Sendai virus
(Ali and Nayak, 2000), measles virus (Ayota et al., 2004; Manié
et al., 2000; Robinzon et al., 2009; Vincent et al., 2000), and New-
castle disease virus (NDV) (Dolganiuc et al., 2003; Laliberte et al.,
2006; Laliberte et al., 2007). In addition, several enveloped viruses
(e.g. Borna disease virus, Ebola virus, Marburg virus) require intact
cell-surface lipid rafts for efﬁcient cellular entry (Bavari et al.,
2002; Clemente et al., 2009). Although several studies have reported
targeting of paramyxovirus proteins to rafts (Ali and Nayak, 2000;
Ayota et al., 2004; Dolganiuc et al., 2003; Laliberte et al., 2006;
Laliberte et al., 2007; Manié et al., 2000; Robinzon et al., 2009;
Vincent et al., 2000), only a few have demonstrated the functional
requirement of cell surface rafts for paramyxovirus infection. As-
sembly of NDV (an avian paramyxovirus) proteins occurs in raft
domains and raft is required for release of infectious NDV particles
(Dolganiuc et al., 2003; Laliberte et al., 2006; Laliberte et al., 2007).
Parainﬂuenza virus 5 (a paramyxovirus that was formerly known
as simian virus 5 or SV5) also requires caveolin (a protein com-
ponent of caveolae which similarly to lipid rafts is enriched with
cholesterol and sphingolipids) for assembly/budding (Ravid, et al., 2010).
Several studies reported that — a) RSV proteins (envelope proteins,
matrix protein, polymerase proteins) are localized in raft domains
(Brown et al., 2002, 2004; Fleming et al., 2006; Marty et al., 2004;
McDonald et al., 2004; Oomens et al., 2006), and b) puriﬁed RSV
virion particles contain raft associated cellular proteins due to incor-
poration of rafts in the virion envelope during budding process
(Brown et al., 2004; Marty et al., 2004; Yeo et al., 2009). Although
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tion, the exact role of rafts during infection is not known. Moreover,
the role of raft during RSV infection of human lung epithelial cells
(the cells productively infected by RSV during infection of the respi-
ratory tract) has not been investigated since previous studies were
primarily conducted in HEp-2 (a human laryngeal cell-line contami-
nated with Hela, a human cervical cell-line) and Vero (African Green
monkey kidney cells) cells (Brown et al., 2002, 2004; Fleming et al.,
2006; Marty et al., 2004; McDonald et al., 2004; Oomens et al.,
2006; Yeo et al., 2009).
In the current study we have examined the role of rafts during
RSV infection of human lung epithelial cells and human ﬁbroblasts
lacking cell-surface raft domains. Our studies revealed that rafts
play a role during RSV life-cycle, since they are critical for release
of infectious progeny virion particles from infected cells. Disruption
of rafts (by the raft disrupting agent methyl-beta-cyclodextrin or
MBCD) in human lung epithelial cells resulted in drastic reduction
in RSV infection. Raft disruption during infection culminated in re-
lease of progeny virion particles with signiﬁcantly reduced infectiv-
ity. Our studies with lung epithelial cells were further validated by
utilizing Niemann–Pick syndrome type C human ﬁbroblasts (NPC)
[these cells lack normal rafts as a result of defective cholesterol traf-
ﬁcking to the plasmamembrane (Ikonen andHoltta-Vuori, 2004; Koike
et al., 1998; Laliberte et al., 2007)] and normal human embryonic
lung (HEL) ﬁbroblasts (wild-type counterpart of NPC cells) (Laliberte
et al., 2007). Our studies with these cells revealed signiﬁcant reduction
in RSV infectivity in NPC cells compared to HEL cells. Further character-
ization demonstrated that reduced infectivity is due to failure of NPC
cells to efﬁciently release infectious RSV virion particles. Thus, our
studies have demonstrated that — a) intact plasma membrane rafts
are required for RSV infection, and b) cell surface rafts are critical
for release of infectious progeny RSV particles.Fig. 1. Plasma membrane rafts are required for RSV infection. (A) RSV infection of untreat
Viral titer was determined at 24 h post-infection by plaque assay. (B) The viral titer values
calculated based on the ratio of pfu/ml obtained from UT cells vs. MBCD+LOV treated A5
sents the mean±standard deviation for three determinations. (C) VSV infection of UT and
plaque assay. (D) RSV infection of UT and MBCD+LOV treated primary normal human b
plaque assay. (E) The viral titer values (pfu/ml) shown in D were utilized to calculate pe
from UT cells vs. MBCD+LOV treated NHBE cells. 100% infectivity corresponds to viral ti
determinations. Plaque assay values shown in A, C and D are expressed as pfu/ml and it rep
deviations are shown by the error bars.Results
Effect of raft disruption on RSV infectivity
Methyl-beta-cyclodextrin (MBCD), a cholesterol-extracting agent
has been extensively utilized to disrupt lipid rafts in the plasmamem-
brane (Allsopp et al., 2010; Laliberte et al., 2006, 2007; Medigeshi
et al., 2008; Xiangjie and Whittaker, 2003; Xu et al., 2009). In order
to study the role of rafts during RSV infection, we treated human
lung epithelial A549 cells with MBCD. A549 cells are airway cells
that are routinely used as a model of type II alveolar epithelial cells.
After 1.5 h adsorption (at 37 °C) of A549 cells with RSV (0.2 MOI),
cells were washed and fresh medium was added in the presence of
5 mM of MBCD. After 1 h incubation with MBCD after virus adsorp-
tion, fresh medium containing lovastatin (4 μg/ml) was added. The
rationale for adding lovastatin is to inhibit cholesterol bio-synthesis
so that cell surface devoid of cholesterol (i.e. loss of cholesterol-rich
lipid rafts) is maintained during the course of infection. After 24 h
post-infection, medium supernatant was collected to determine viral
titer by plaque assay analysis. Treatment of A549 cells with MBCD
resulted in signiﬁcant decrease in RSV infectivity (inhibited by 85%–
90%) compared to untreated cells (Figs. 1A and B). The effect of MBCD
is speciﬁc for RSV, since similar MBCD treatment of A549 cells did
not alter Vesicular Stomatitis Virus (VSV) infection (Fig. 1C).
We next evaluated the requirement of raft during RSV infection of
primary normal human bronchial epithelial (NHBE) cells. Similar to
A549 cells, NHBE cells were incubated with RSV (0.2 MOI) for 1.5 h.
After adsorption, fresh medium containing 5 mM MBCD was added
to washed cells. Following 1 h MBCD treatment, cells were washed
and incubated with lovastatin. At 48 h post-infection, medium super-
natant was collected to determine RSV titer by plaque assay analysis.
Cell surface rafts are also required for RSV infection of NHBE cells,ed (UT) and methyl-beta-cyclodextrin+lovastatin (MBCD+LOV) treated A549 cells.
(pfu/ml) shown in A were utilized to calculate percent (%) infection. % infection was
49 cells. 100% infectivity corresponds to viral titer in UT cells. % infection value repre-
MBCD+LOV treated A549 cells. Viral titer was determined at 24 h post-infection by
ronchial epithelial (NHBE) cells. Viral titer was determined at 48 h post-infection by
rcent (%) infection. % infection was calculated based on the ratio of pfu/ml obtained
ter in UT cells. % infection value represents the mean±standard deviation for three
resents mean±standard deviations for three independent determinations. Standard
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MBCD treated cells, compared to control (MBCD untreated) cells
(Figs. 1D and E). The experimental procedure for the above men-
tioned studies are presented schematically in supplemental Figs. S1A
and S1B.
Previously 5 mM–10 mMMBCDwas used to disrupt cell surface or
virus associated raft domains (Allsopp et al., 2010; Laliberte et al.,
2006, 2007; Medigeshi et al., 2008; Xiangjie and Whittaker, 2003;
Xu et al., 2009). In order to examine raft status in A549 cells, cells
(untreated and MBCD treated) were incubated with FITC conjugated
cholera-toxin subunit-B (CHTX), which speciﬁcally binds to the cell
surface raft resident ganglioside GM1 (Harder et al., 1998). Based
on the GM1 binding property of CHTX, it has been widely used to
visualize lipid-rafts on the cell surface (Harder et al., 1998). A549
cells were incubated with 5 mM MBCD for 1 h. The cells were then
washed and fresh medium containing lovastatin (4 μg/ml) was added.
At 16 h post-treatment with lovastatin, cells were incubated with
FITC-CHTX. FITC-CHTX incubated cells were ﬁxed and visualized by
confocalmicroscopy. As shown in Fig. 2A,while a cell surface ring repre-
senting the plasma membrane rafts were prominent in untreated cells,
MBCD treatment led to disappearance of the raft structures. Interest-
ingly, MBCD treatment led to intracellular clustering of GM1. The
ability of MBCD to reduce cholesterol levels in A549 cells was also
investigated. A549 cells were treated with MBCD and lovastatin as
described above for FITC-CHTX labeling studies. The loss of cellular
cholesterol levels following MBCD treatment was also evident from
presence of signiﬁcantly less cholesterol in MBCD treated A549 cells
compared to untreated cells (Fig. 2B) (Table 1). Similar to A59 cells,
we also observed loss of cell surface rafts and signiﬁcant reduction in
cellular cholesterol levels in NHBE cells treated with 5 mM MBCD for
1 h (data not shown). Treatment of A549 and NHBE cells with 5 mM
MBCD (for 1 h) and lovastatin (for 24 h–48 h) was not toxic during the
time-frame of our experiment as deduced by trypan blue exclusion
viability assay (data not shown). Please note that similar toxicity
assays were performed for all the experiments described in Fig. 1. Our
studies have demonstrated that rafts are critical for RSV infection of
both human alveolar epithelial (A549 cells) cells and primary human
bronchial epithelial (NHBE cells) cells.
Intact rafts are critical for release of infectious RSV particles
Rafts may play an important role during post-entry stages of RSV
life-cycle, since addition of MBCD following adsorption inhibited
virus infection (Fig. 1). We speculated that rafts may be required forFig. 2. Effect of methyl-beta-cyclodextrin (MBCD) on raft structure and cholesterol levels. (
toxin (CHTX) subunit (green) and DAPI (blue, nucleus) following treatment with MBCD+l
astatin containing fresh medium for additional 16 h). (B) Untreated (UT) and MBCD+LOV (
fresh medium for additional 16 h) treated A549 cells were used to estimate total cholester
concentration, the total cholesterol content was expressed as percentage of control. The co
±standard deviation values.RSV release/budding because assembly/budding of numerous envel-
oped viruses occurs in the raft domains of the plasma membrane.
Moreover, RSV proteins accumulate in the raft domain of infected
cells. In order to examine this possibility, we performed an infectious
virus release/budding assay as described previously (Bose et al.,
2001). A549 cells were infected with RSV (1 MOI) for 8 h and then
treated with MBCD (5 mM for 1 h). After washing, fresh medium
was added in the presence of lovastatin (4 μg/ml) and cycloheximide
(30 μg/ml cycloheximide was added to accumulate an intracellular
viral protein pool in the absence of de novo protein synthesis.). Fol-
lowing 3 h incubation, cells were washed 3× and once again fresh
medium (± lovastatin, but with no cycloheximide) was added to
the cells to examine the release/budding of the accumulated viral
proteins as virion particle in the presence of intact (cells not incubat-
ed with MBCD and lovastatin) and disrupted (MBCD and lovastatin
treated cells) rafts. After 12 h the medium supernatants were
assessed for viral titer by plaque assay. The budding assay revealed
that loss of rafts resulted in diminished release of infectious RSV by
80%–85% (Figs. 3A and B). The experimental procedure for the studies
described in Fig. 3 is presented schematically in supplemental Fig. S2.
Inhibition of RSV release from raft disrupted cells could be due to
several reasons — a) abnormal assembly of viral proteins occurs in
raft disrupted cells, resulting in budding blockade; in this case proge-
ny virion particles will not be present in the medium supernatant, b)
normal assembly/budding occurs from raft disintegrated cells, but the
progeny virion particles are defective and non-infectious probably due
to lack of viral proteins (especially envelope proteins that are required
for cellular entry), c) progeny virion particles possess viral proteins,
but the particle is non-infectious since it is devoid of virion envelope-
associated rafts, which is required for initiating subsequent infection.
In order to examine these possibilities, we studied viral protein
composition of puriﬁed virions obtained from the medium superna-
tants of infected cells. These studies were performed essentially sim-
ilar to the budding assay (± MBCD as described above for Fig. 3), but
the cells were labeled with 35S-methionine and the experiment was
performed in a larger scale (to recover larger amount of puriﬁed virus
for analysis). The radioactive medium supernatant obtained from
untreated andMBCD treated cells was utilized to purify 35S-methionine
labeled RSV (35S-RSV) particles. Puriﬁed 35S-RSV was then subjected to
SDS-PAGE and autoradiography. As shown in Fig. 4A, disruption of rafts
did not result in inhibition of assembly/budding of virion particles, since
virions derived from both untreated and MBCD treated cells comprised
similar levels of viral proteins. Protein assay analysis also did not dem-
onstrate any signiﬁcant difference in total protein content of puriﬁedA) Fluorescence confocal microscopic analysis of A549 cells labeled with FITC-cholera
ovastatin (LOV) (cells incubated with 5 mM MBCD for 1 h, followed by addition of lov-
cells incubated with 5 mM MBCD for 1 h, followed by addition of lovastatin containing
ol content by cholesterol quantitation assay kit. Following normalization with protein
ntrol cells are UT cells and are represented as 100%. Please see Table 1 for the mean
Table 1
Cholesterol estimation of A549 cells and puriﬁed RSV virion particles.
aCells±MBCD+LOV treatment
(nmol/mg cellular protein)
bRSV puriﬁed from medium supernatant±MBCD+LOV treatment
(nmol/mg viral protein)
Untreated 280.6±46.6 262.3±43.3
MBCD+LOV treated 64.7±10.4 88.1±12.8
The results are means±standard deviations.
a Total cholesterol was measured in A549 cells incubated with 5 mM methyl-beta-cyclodextrin (MBCD) for 1 h, followed by addition of fresh medium containing lovastatin
(LOV). Cholesterol was measured at 16 h following LOV addition. Untreated cells were not treated with MBCD and LOV.
b A549 cells were infected with RSV for 8 h. At 8 h post-infection, cells were incubated with MBCD (5 mM) for 1 h, followed by addition of fresh medium containing LOV. After
16 h, RSV was puriﬁed from the medium supernatant. Untreated; cholesterol content of RSV virion particle puriﬁed from the medium supernatant of infected cells not treated with
MBCD and LOV.
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not shown). The experimental procedure for the studies described
in Fig. 4A is presented schematically in supplemental Fig. S3.
Although the progeny virions recovered from the medium of
untreated and MBCD treated cells had similar protein composition,
we examined the cholesterol content of the puriﬁed virion particles.
As described above, medium supernatant from untreated and MBCD
treated cells were utilized to purify RSV particles. The total cholester-
ol content of these puriﬁed virion particles was assayed. The choles-
terol content of puriﬁed RSV particles obtained from MBCD treated
cells was signiﬁcantly less compared to particles obtained from
untreated cells (Fig. 4B) (Table 1). These results suggested that cell
surface raft serves as a platform for release of infectious RSV virion
particles from infected cells. Moreover, raft is required for enrichment
of cholesterol in the RSV virion particles.
RSV infection of cells deﬁcient in plasma membrane cholesterol
In the above studies we have utilized MBCD to disrupt raft micro-
domains. In order to provide further evidence for the role of rafts
during RSV infection, we utilized Niemann–Pick syndrome type C
human ﬁbroblasts (NPC cells). NPC cells are human ﬁbroblasts that
harbor mutations in either NPC1 and/or NPC2 genes (Ikonen and
Holtta-Vuori, 2004; Koike et al., 1998; Laliberte et al., 2007). Due to
these mutations, cholesterol trafﬁcking to the plasma membrane in
these cells is defective and as a consequence these cells do not pos-
sess functional plasma membrane lipid rafts. These cells have been
widely used to study the role of rafts in various cellular processes
(Henderson et al., 2000), including its role during virus (e.g. NDV,
HIV-1) infection (Laliberte et al., 2007; Tang et al., 2009).
RSV infection of NPC and HEL [normal human embryonic lung
(HEL) ﬁbroblasts were used as the wild-type counterpart to compareFig. 3. Rafts are essential for release of infectious RSV particle. (A) Untreated (UT) and meth
RSV in the presence of cycloheximide as detailed in the supplemental Fig. S2 and in the Mate
medium supernatant to assess infectious viral titer by plaque assay. Plaque assay values are e
determinations. Standard deviations are shown by the error bars. (B) The plaque assay valu
infectious RSV release was calculated based on the ratio of pfu/ml obtained from UT cells vs
cells. % infectious RSV release value represents the mean±standard deviation for three detwith mutant NPC cells (Laliberte et al., 2007; Tang et al., 2009)] cells
revealed signiﬁcantly diminished cytopathic effect of RSV upon infec-
tion of NPC cells compared to HEL cells (Fig. 5A). The observed cyto-
pathic effect in HEL could be due to enhanced syncytia in HEL cells
compared to NPC cells. Since syncytia occur due to cell–cell fusion
mediated by RSV fusion protein, it reﬂects the infection efﬁciency.
Thus, enhanced cytopathic effect (due to syncytia) observed in HEL
cells suggested enhanced infectivity of these cells compared to NPC
cells. In order to determine whether reduced cytopathic effect in
cholesterol deﬁcient NPC cells was due to reduced RSV infectivity,
we infected HEL and NPC cells with RSV (0.5 MOI). At 36 h post-
infection, medium supernatant was collected to determine RSV
titer by plaque assay analysis. Indeed, RSV infection was drastically
reduced (by 90%) in NPC cells compared to HEL cells (Figs. 5B and
C). In contrast, no signiﬁcant difference in infectivity was observed
following infection of HEL and NPC cells with VSV (Fig. 5D). The
experimental procedure for the studies described in Fig. 5B is pre-
sented schematically in supplemental Fig. S4A.
We speculated that reduced RSV infectivity in NPC cells could be
as a consequence of defective release of infectious RSV particles,
since rafts play an essential role during this process (Fig. 3). There-
fore, we performed virus release/budding assay as described above
for A549 cells. HEL and NPL cells were infected with RSV (1 MOI).
At 10 h post-infection, cells were washed and the medium was
replaced with fresh medium containing cycloheximide (30 μg/ml) to
accumulate an intracellular viral protein pool in the absence of de
novo protein synthesis. Following 3 h incubation with cycloheximide,
cells were washed 3× and once again fresh medium (in the absence
of cycloheximide) was added to the cells to promote release/budding
of the accumulated viral proteins as virion particles. After 12 h, the
medium supernatants were assessed for viral titer by plaque assay.
Similar to lung epithelial cells, we also observed defective release ofyl-beta-cyclodextrin+lovastatin (MBCD+LOV) treated A549 cells were infected with
rials and methods section. Infectious RSV release efﬁciency was determined by utilizing
xpressed as pfu/ml and it represents mean±standard deviations for three independent
es (pfu/ml) shown in A were utilized to calculate percent (%) infectious RSV release. %
. MBCD+LOV treated cells. 100% infectious RSV release corresponds to viral titer in UT
erminations.
Fig. 4. Effect of raft disruption on RSV budding and cholesterol content of progeny RSV virion particles. (A) Untreated (UT) and methyl-beta-cyclodextrin+lovastatin (MBCD
+LOV) treated A549 cells were infected with RSV as detailed in the ﬁgure and in the Materials and methods section. After infection, cells were labeled with 35S-methionine to pro-
mote budding of radiolabeled RSV particles. Radiolabeled RSV was puriﬁed from the medium supernatant of UT and MBCD treated cells. Puriﬁed 35S-methionine-RSV was subject to
SDS-PAGE and autoradiography to visualize radiolabeled viral proteins. (B) UT and MBCD+LOV treated A549 cells were infected with RSV as detailed in the Materials and methods
section. RSV was puriﬁed from the medium supernatant of UT and MBCD+LOV treated cells. Puriﬁed RSV was utilized to estimate cholesterol content by cholesterol quantitation
assay kit. Following normalization with protein concentration, the total cholesterol content was expressed as percentage of control virus. The control virus is virion particles
obtained from UT cells and is represented as 100%. Please see Table 1 for the mean±standard deviation values.
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normal HEL cells (Figs. 6A and B), although viral protein levels in the
puriﬁed virions derived from NPC and HEL cells were similar (data
not shown). Moreover, cholesterol content of NPC cell derived virion
particles was signiﬁcantly less compared to puriﬁed virus obtained
from HEL cells (data not shown). The experimental procedure for
the studies described in Fig. 6 is presented schematically in supple-
mental Fig. S4B. Thus, our studies have demonstrated that plasma
membrane cholesterol rich raft domain is required for RSV infection,
by virtue of its role in release of infectious progeny RSV particles
from infected cells.
Discussion
Plasma membrane resident cholesterol and sphingolipid enriched
lipid rafts play an important role in cellular entry and assembly/
morphogenesis of both segmented and non-segmented negative-
sense ssRNA viruses (Ali and Nayak, 2000; Ayota et al., 2004;
Bavari et al., 2002; Clemente et al., 2009; Dolganiuc et al., 2003;
Laliberte et al., 2006, 2007; Leser and Lamb, 2005; Manié et al.,
2000; Robinzon et al., 2009; Scheiffele et al., 1999; Takeda et al.,
2003; Vincent et al., 2000; Xiangjie and Whittaker, 2003). Proteins
of several paramyxoviruses (non-segmented (–)ssRNA viruses) are
also targeted to the raft domains of infected cells (e.g. Sendai
virus, RSV, measles) (Ali and Nayak, 2000; Brown et al., 2002,
2004; Fleming et al., 2006; Manié et al., 2000; Marty et al., 2004;
McDonald et al., 2004; Oomens et al., 2006). Few studies have
reported an essential function of rafts during paramyxovirus infec-
tion. Rafts play a role during NDV (an avian paramyxovirus) infec-
tion (Dolganiuc et al., 2003; Laliberte et al., 2006, 2007) since it is
required for release of infectious NDV particles. Budding of parain-
ﬂuenza 5 virus requires caveolin, a component of raft-like structure
known as caveolae (Ravid et al., 2010). In the current study we dem-
onstrated that rafts play an important role during RSV infection. Spe-
ciﬁcally, raft is required for release of infectious progeny RSV
particles. Our studies revealed that raft (and cholesterol) is not re-
quired for RSV budding from infected cells. However, theinfectiousness of released raft (and cholesterol) deﬁcient RSV parti-
cles is severely compromised.
RSV is a lung-tropic virus that causes severe respiratory diseases
during infancy, childhood, old age. The high morbidity and mortality
associated with RSV infection is due to its ability to cause respiratory
diseases like pneumonia and bronchiolitis (Collins et al., 2007; Hall,
2001; Hippenstiel et al., 2006). Several studies have suggested that
rafts may play an important role during RSV life-cycle — a) RSV pro-
teins associate with plasma membrane rafts during assembly, b) raft
associated proteins were observed in puriﬁed RSV virion particles,
and c) ﬁlamentous virion particle formation requires intact raft struc-
ture (Brown et al., 2002, 2004; Fleming et al., 2006; Marty et al., 2004;
McDonald et al., 2004; Oomens et al., 2006; Yeo et al., 2009). The
cholesterol lowering drug lovastatin also diminished RSV infection
of HEp2 cells (the human cervical carcinoma cell-line) (Gower and
Graham, 2001). However, the direct role of cholesterol during RSV
infection was not evaluated in these cells using a cholesterol-speciﬁc
drug. Moreover, the role of cholesterol rich raft during RSV life-cycle
was unknown. In the current study we have illustrated that rafts
are required for release of infectious progeny RSV virion particle.
Lipid raft domains are localized on the exoplasmic side of the plas-
ma membrane and are enriched with cholesterol and sphingolipids
(Pike, 2003; Silvius, 2003). The raft domain forms a localized rigid
(less ﬂuid) environment due to the clustering of cholesterol mole-
cules and the saturated fatty acyl chains of the sphingolipids. Various
proteins (e.g. GPI-anchored CD59 protein, caveolin-1 etc) have high
afﬁnity for lipid rafts and therefore, they partition themselves in the
raft domains. Such partitioning may occur during intracellular traf-
ﬁcking, whereby these proteins segregate in the lipid rafts of vesicles
destined to deliver their cargo to the plasma membrane. Plasma
membrane rafts have multiple functions during normal cellular pro-
cesses. They play an important role during intracellular trafﬁcking/
targeting originating from the cell surface and are required for cell-
to-cell adhesion. Apart from these functions, rafts act as a cell surface
platform for initiating key signal transduction pathways (Ning et al.,
2006; Simons and Toomre, 2000). The rigid (less ﬂuid) micro-
environment in the plasma membrane provided by the cholesterol
Fig. 5. RSV infection of cholesterol deﬁcient human ﬁbroblasts — (A) morphology of mock-infected or RSV-infected (36 h post-infection) cholesterol-deﬁcient Niemann–Pick syn-
drome type C human ﬁbroblasts (NPC cells) and normal human embryonic lung (HEL cells) ﬁbroblasts (wild-type counterpart of NPC cells). (B) RSV infection of NPC and HEL cells.
Viral titer was determined at 36 h post-infection by plaque assay. (C) The viral titer values (pfu/ml) shown in B was utilized to calculate percent (%) RSV infection. % RSV infection
was calculated based on the ratio of pfu/ml obtained from HEL cells vs. NPC cells. 100% infectivity corresponds to viral titer in HEL cells. % infection value represents the mean
±standard deviation for three determinations. (D) VSV infection of NPC and HEL cells. Viral titer was determined at 36 h post-infection by plaque assay. Plaque assay values
shown in B and D are expressed as pfu/ml and these represent mean±standard deviations for three independent determinations. Standard deviations are shown by the error bars.
210 T.-H. Chang et al. / Virology 422 (2012) 205–213and sphingolipids (key components of rafts) facilitates homotypic and
heterotypic interaction between plasma membrane associated proteins/
receptors. These interactions may only occur in the raft “micro-domains”
since rigid (less ﬂuid) environment provides limited ﬂexibility to raft res-
ident proteins which promotes their functional interactions.Fig. 6. Release of infectious RSV particle is disrupted in cholesterol deﬁcient human ﬁbrobla
detailed in the supplemental Fig. S4B and in the Materials and methods section. Infectious R
tious viral titer by plaque assay. Plaque assay values are expressed as pfu/ml and these repr
viations are shown by the error bars. (B) The plaque assay values (pfu/ml) shown in A w
infectious RSV release was calculated based on the ratio of pfu/ml obtained from HEL cells v
tious RSV release value represents the mean±standard deviation for three determinationsOur study demonstrated that intact cell surface rafts are essential
for release of progeny infectious RSV particles from infected cells. In
context to enveloped viruses it is speculated that intracellular-
trafﬁcking/seclusion of viral membrane associated proteins (e.g. RSV
envelope proteins F and G and matrix protein M associates withsts. (A) HEL and NPC cells were infected with RSV in the presence of cycloheximide as
SV release efﬁciency was determined by utilizing medium supernatant to assess infec-
esent mean±standard deviations for three independent determinations. Standard de-
ere utilized to calculate percent (%) infectious RSV release from NPC and HEL cells. %
s. NPC cells. 100% infectious RSV release corresponds to viral titer in HEL cells. % infec-
.
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for assembly and budding. In addition, cellular proteins involved in
viral release (Harty et al., 2001; Irie et al., 2004; Okumura et al.,
2008; Usami et al., 2009) may also localize in rafts to facilitate assem-
bly/budding of progeny virion particles. For example, Rho A (Gower
et al., 2001, 2005; Pastey et al., 2000) and FIP2 (Rab11 family inter-
acting protein 2) (Utley et al., 2008) have been shown to play an im-
portant role during RSV budding. Rho A activation by RSV is
required for ﬁlamentous virus formation during morphogenesis
(Gower et al., 2005). However, active Rho A is dispensable for
RSV infection (Gower et al., 2005). Interestingly, both Rho A and
FIP2 have been implicated in functioning via raft domain of plas-
ma membrane (Chu et al., 2009; Lacalle et al., 2002). One could
envision that raft disruption leads to RSV budding defect due to
lack of functional scaffolding of host proteins like FIP2. However,
it is a highly unlikely scenario, since virus budding was preserved
following plasma membrane raft disruption (Fig. 4A) as deduced
from the viral protein content of the puriﬁed virion particles. In
contrary, our study suggested that release of infectious RSV parti-
cle was compromised following raft disruption. In that context, we
also observed reduced virion-associated cholesterol levels in RSV
particles released from raft disrupted cells (Fig. 4B, Table. 1). In
the future, we will investigate the role of virion associated choles-
terol (and rafts) in the RSV infection process.
In summary, our study has uncovered a critical role of rafts during
RSV infection. Rafts are required for release of infectious RSV virion
particles, since intact raft domains are necessary for “loading” choles-
terol into the RSV virion particle.
Conclusions
Plasma membrane cholesterol-rich lipid rafts play a critical role
during RSV infection, since raft domains are required for release of in-
fectious progeny RSV virion particles.
Materials and methods
Virus and cells
RSV (A2 strain) was propagated in CV-1 cells (Kota et al., 2008;
Sabbah et al., 2009). VSV (Indiana serotype, Mudd–Summers strain)
was propagated in BHK-21 cells (Basu et al., 2006; Bose et al.,
2003). RSV and VSV were puriﬁed by centrifugation on discontinuous
sucrose gradients as described previously (Ueba, 1978). Human lung
epithelial A549 cells and normal primary human bronchial epithelial
cells (NHBE cells were purchased from Lonza) were maintained in
DMEM (supplemented with 10% fetal calf serum or FCS, penicillin,
streptomycin, and glutamine) and Bronchial Epithelial Cell Basal
Medium (containing BPE, Hydrocortisone, hEGF, Epinephrine, Transfer-
rin, Insulin, Retinoic Acid, Triiodothyronine, GA-1000) (Clonetics/
Lonza), respectively. Normal human embryonic lung (HEL) ﬁbroblasts
(ATCC) and Niemann–Pick syndrome type C human (NPC) ﬁbroblasts
(NIH-Coriell Cell Repository) were maintained in DMEM (supplemen-
ted with 10% FCS, non-essential amino acids, glutamine, vitamins).
RSV titer was monitored by plaque assay analysis with CV-1 cells as
described earlier (Kota et al., 2008; Sabbah et al., 2009).
Virus infection
To study the role of rafts during RSV infection, A549 and NHBE
cells were treated with cholesterol disrupting drug methyl-beta-
cyclodextrin (MBCD) (Sigma-Aldrich). Cells were treated with
MBCD after virus adsorption stage. RSV (0.2 MOI) or VSV (0.1 MOI)
was added to cells (A549 and NHBE) for 1.5 h (adsorption stage). Fol-
lowing adsorption, the cells were washed and fresh medium contain-
ing 5 mM MBCD was added. After 1 h MBCD incubation, cells werewashed and once again fresh medium was added in the presence
(for MBCD treated cells) or absence (control cells) of lovastatin
(Sigma-Aldrich) (4 μg/ml). Medium supernatant was collected at ei-
ther 24 h (for A549) or 48 h (for NHBE) post infection to assess viral
titer by plaque assay.
HEL and NPC cells were also infected with RSV (0.5 MOI) or VSV
(0.5 MOI). At 36 h post-infection, medium supernatant was utilized
to assess viral titer by plaque assay. In addition, light microscope
was utilized to visualize cell morphology and cytopathic effect in
RSV infected HEL and NPC cells.
Virus release assay
Virus release or budding assay was essentially performed as de-
scribed previously (Bose et al., 2001). In order to investigate the ef-
fect of raft disruption (i.e. MBCD treatment) on RSV release, A549
cells were infected with RSV (1 MOI). At 8 h post-infection, fresh
medium containing MBCD (5 mM) was added to washed cells and
the cells were incubated with MBCD for 1 h at 37 °C. After 1 h,
cells were washed and fresh medium was added in the presence of
lovastatin (4 μg/ml) and cycloheximide (30 μg/ml cycloheximide
was added to accumulate an intracellular viral protein pool in the
absence of de novo protein synthesis). Following 3 h of incubation,
cells were washed and fresh medium (± lovastatin, but with no cy-
cloheximide) was added to the cells to examine the assembly and
release/budding of the accumulated viral proteins as virion parti-
cles in the presence of intact (MBCD and lovastatin untreated
cells) and disrupted (MBCD and lovastatin treated cells) rafts. After
12 h the medium supernatants were assessed for viral titer by plaque
assay.
Budding assay with NPC and HEL cells was performed similar to
A549 cells but devoid of MBCD treatment. NPC and HEL cells were
infected with RSV (1 MOI). At 10 h post-infection, fresh medium con-
taining cycloheximide (30 μg/ml cycloheximide was added to accu-
mulate an intracellular viral protein pool in the absence of de novo
protein synthesis) was added to washed cells and the cells were
incubated with cycloheximide for 3 h. Following 3 h of incubation,
cells were washed and fresh medium (with no cycloheximide)
was added to the cells to examine the assembly and release/budding
of the accumulated viral proteins as virion particles. After 12 h the
medium supernatants were assessed for viral titer by plaque assay.
Radioactive labeling
The viral protein composition of released progeny virus was ex-
amined by labeling cells with 35S-methionone. A549 cells were
infected with RSV (2 MOI). At 8 h post-infection, cells were washed
and incubated with fresh medium containing 5 mM MBCD. After
1 h, MBCD medium was replaced with methionine free medium
containing ± lovastatin (4 μg/ml). Following 2 h of incubation
with methionine free medium, cells were pulsed with 35S-methio-
none for 4 h. The radioactive medium was replaced with medium
containing cold methionine ± lovastatin. After 12 h, 35S-RSV was
puriﬁed from medium supernatant and the radioactive virus was
subjected to SDS-PAGE and autoradiography to visualize viral pro-
tein composition.
Immunoﬂuorescence analysis
A549 cells grown on coverslips were either untreated or incubat-
ed with 5 mM MBCD for 1 h. Fresh medium containing lovastatin
(4 μg/ml) was added to washed cells. After 16 h, cells were incubated
with FITC conjugated cholera-toxin subunit-B (CHTX) (Sigma-Al-
drich). Cells were ﬁxed with 3.7% formaldehyde in PBS and visual-
ized by confocal microscopy (Leica CISM confocal laser-scanning
microscope).
212 T.-H. Chang et al. / Virology 422 (2012) 205–213Cholesterol estimation assay
Untreated and MBCD treated cells were lysed and total cholesterol
content was measured by cholesterol quantitation kit (MBL Intl)
according to the manufacturer's speciﬁcation. Virion cholesterol
amount was also estimated in puriﬁed RSV virion particles (RSV puri-
ﬁed from the medium supernatant) by using the cholesterol quantita-
tion kit (MBL Intl).
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